Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 202.54 |
| Open | 202.54 |
| Bid | 193.20 x 800 |
| Ask | 202.29 x 1000 |
| Day's range | 198.10 - 203.32 |
| 52-week range | 187.16 - 468.55 |
| Volume | |
| Avg. volume | 1,095,843 |
| Market cap | 29.636B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 20.71 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study
The FDA places clinical hold on INmune Bio's (INMB) IND application to begin a phase II study on the investigational TNF inhibitor, XPro1595, for Alzheimer's disease.
- Simply Wall St.
How Many Biogen Inc. (NASDAQ:BIIB) Shares Do Institutions Own?
If you want to know who really controls Biogen Inc. ( NASDAQ:BIIB ), then you'll have to look at the makeup of its...
- Zacks
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
© 2022 Yahoo. All rights reserved.
